Form 8-K - Current report:
SEC Accession No. 0001564590-19-036823
Filing Date
2019-10-11
Accepted
2019-10-11 11:49:21
Documents
14
Period of Report
2019-10-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20191011.htm   iXBRL 8-K 46167
2 EX-99.1 fgen-ex991_6.htm EX-99.1 42441
3 GRAPHIC geapbbklwiq5000001.jpg GRAPHIC 4406
  Complete submission text file 0001564590-19-036823.txt   231550

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fgen-20191011.xsd EX-101.SCH 6196
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20191011_lab.xml EX-101.LAB 19067
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20191011_pre.xml EX-101.PRE 11720
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20191011_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191147514
SIC: 2834 Pharmaceutical Preparations